SanBio Company Statistics

Total Valuation

SanBio Company has a market cap or net worth of JPY 81.57 billion. The enterprise value is 79.99 billion.

Market Cap	81.57B
Enterprise Value	79.99B

Important Dates

The next estimated earnings date is Monday, March 17, 2025.

Earnings Date	Mar 17, 2025
Ex-Dividend Date	n/a

Share Statistics

SanBio Company has 70.93 million shares outstanding. The number of shares has increased by 5.87% in one year.

Current Share Class	n/a
Shares Outstanding	70.93M
Shares Change (YoY)	+5.87%
Shares Change (QoQ)	-0.00%
Owned by Insiders (%)	27.25%
Owned by Institutions (%)	-4.64%
Float	50.61M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	127.98
P/TBV Ratio	142.40
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-27.45
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.80, with a Debt / Equity ratio of 0.75.

Current Ratio	3.80
Quick Ratio	3.17
Debt / Equity	0.75
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-377.92

Financial Efficiency

Return on equity (ROE) is -233.60% and return on invested capital (ROIC) is -111.68%.

Return on Equity (ROE)	-233.60%
Return on Assets (ROA)	-60.04%
Return on Invested Capital (ROIC)	-111.68%
Return on Capital Employed (ROCE)	-171.84%
Revenue Per Employee	n/a
Profits Per Employee	-100.47M
Employee Count	29
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +69.37% in the last 52 weeks. The beta is 0.42, so SanBio Company's price volatility has been lower than the market average.

Beta (5Y)	0.42
52-Week Price Change	+69.37%
50-Day Moving Average	829.04
200-Day Moving Average	898.44
Relative Strength Index (RSI)	77.09
Average Volume (20 Days)	2,167,705

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-3.30B
Pretax Income	-2.80B
Net Income	-2.91B
EBITDA	-3.29B
EBIT	-3.30B
Earnings Per Share (EPS)	-42.82

Full Income Statement

Balance Sheet

The company has 2.04 billion in cash and 464.00 million in debt, giving a net cash position of 1.57 billion or 22.19 per share.

Cash & Cash Equivalents	2.04B
Total Debt	464.00M
Net Cash	1.57B
Net Cash Per Share	22.19
Equity (Book Value)	616.68M
Book Value Per Share	8.99
Working Capital	1.80B

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SanBio Company does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.87%
Shareholder Yield	-5.87%
Earnings Yield	-3.57%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a